Literature DB >> 33455359

Facile Fabrication Route of Janus Gold-Mesoporous Silica Nanocarriers with Dual-Drug Delivery for Tumor Therapy.

Yang Xing1, Ying Zhou1, Yan Zhang1, Caihong Zhang1, Xu Deng2, Chuan Dong3, Shaomin Shuang1.   

Abstract

Codelivery of drugs using multifunctional nanoplatforms with anisotropic properties can produce synergistic effects and improve the antitumor activity of the drugs. In this work, Janus gold-mesoporous silica nanoparticles have been successfully synthesized via the Pickering emulsion method. The obtained Janus nanoparticles were further selectively assembled with thiol-β-cyclodextrin as a drug delivery vehicle for paclitaxel on gold domains, while the other mesoporous silica side with a mesoporous structure served as a drug delivery vehicle for doxorubicin. These synthesized Janus nanoparticles possess pH and near-infrared (NIR) dual-responsive release properties. Furthermore, the tumor-bearing mice treated with dual-drug-loaded Janus nanoparticles showed obvious tumor inhibition than single-drug-loaded ones. Histological analysis reveals no pathological changes in the vital organs of the mice. The outcome demonstrated that dual-drug-loaded Janus gold-mesoporous silica nanoparticles possessed a high therapeutic efficiency and excellent biocompatibility both in vitro and in vivo and could be used as an effective candidate for cancer therapeutics.

Entities:  

Keywords:  Janus nanoparticles; anisotropy; cancer therapy; codelivery; gold-mesoporous silica

Mesh:

Substances:

Year:  2020        PMID: 33455359     DOI: 10.1021/acsbiomaterials.0c00042

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  7 in total

Review 1.  Progress in Mesoporous Silica Nanoparticles as Drug Delivery Agents for Cancer Treatment.

Authors:  Eleen Dayana Mohamed Isa; Haslina Ahmad; Mohd Basyaruddin Abdul Rahman; Martin R Gill
Journal:  Pharmaceutics       Date:  2021-01-24       Impact factor: 6.321

Review 2.  Recent Progress on Asymmetric Carbon- and Silica-Based Nanomaterials: From Synthetic Strategies to Their Applications.

Authors:  Haitao Li; Liang Chen; Xiaomin Li; Daoguang Sun; Haijiao Zhang
Journal:  Nanomicro Lett       Date:  2022-01-17

Review 3.  Stimuli-Responsive Drug Delivery Systems for the Diagnosis and Therapy of Lung Cancer.

Authors:  Xu Lin; Jiahe Wu; Yupeng Liu; Nengming Lin; Jian Hu; Bo Zhang
Journal:  Molecules       Date:  2022-01-30       Impact factor: 4.411

Review 4.  Nanoscale Drug Delivery Systems in Glioblastoma.

Authors:  Zihao Liu; Xiaoshuai Ji; Dong He; Rui Zhang; Qian Liu; Tao Xin
Journal:  Nanoscale Res Lett       Date:  2022-02-16       Impact factor: 5.418

5.  Janus Magnetic Nanoplatform for Magnetically Targeted and Protein/Hyperthermia Combination Therapies of Breast Cancer.

Authors:  Shuting Zuo; Jing Wang; Xianquan An; Yan Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-03-08

Review 6.  Multifunctional co-transport carriers based on cyclodextrin assembly for cancer synergistic therapy.

Authors:  Shouhui Yi; Rongqiang Liao; Wei Zhao; Yusheng Huang; Yi He
Journal:  Theranostics       Date:  2022-02-28       Impact factor: 11.600

Review 7.  Recent Advances in pH- or/and Photo-Responsive Nanovehicles.

Authors:  Yuseon Shin; Patihul Husni; Kioh Kang; Dayoon Lee; Sehwa Lee; Eunseong Lee; Yuseok Youn; Kyungtaek Oh
Journal:  Pharmaceutics       Date:  2021-05-14       Impact factor: 6.321

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.